Curriculum vitae




НазваниеCurriculum vitae
страница14/15
Дата14.10.2012
Размер1.04 Mb.
ТипДокументы
1   ...   7   8   9   10   11   12   13   14   15
Davis S, Hacke W, Fierus M, Saver JL. Serum calcium as prognosticator in ischemic stroke. Stroke. 2008;39:2231-2236

260. Pearce DC, Cadilhac DA, Pierce RJ, Thrift AG, David S, Donnan GA. Estimating the prevalence of sleep-disordered breathing in community-based, long-term stroke survivors using a validated predictive model. Cerebrovasc Dis. 2008;26:441-446

261. Steiner T, Broderick J, Brun NC, Davis S, Diringer MN, Mayer S, Skolnick BE. Timing is everything in intracerebral hemorrhage. Stroke. 2008;39:e117-118; author reply e119-120

262. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S, Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL, Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Kohrmann M, Koroshetz W, Lee TY, Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P, Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S. Acute stroke imaging research roadmap. AJNR Am J Neuroradiol. 2008;29:e23-30

263. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S, Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL, Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Kohrmann M, Koroshetz W, Lee TY, Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P, Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S. Acute stroke imaging research roadmap. Stroke. 2008;39:1621-1628

264. Barras CD, Tress BM, Christensen S, MacGregor L, Collins M, Desmond PM, Skolnick BE, Mayer SA, Broderick JP, Diringer MN, Steiner T, Davis S. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke. 2009;40:1325-1331

265. Davis S, Donnan G. The ECASS III results and the tPa paradox. Int J Stroke. 2009;4:17-18

266. Davis S, Donnan GA. MR mismatch and thrombolysis: Appealing but validation required. Stroke. 2009;40:2910

267. Davis S, Donnan GA. Antiplatelet activity. Stroke. 2009;40:2275

268. Davis S, Donnan GA. 4.5 hours: The new time window for tissue plasminogen activator in stroke. Stroke. 2009;40:2266-2267

269. De Silva DA, Ebinger M, Davis S. Gender issues in acute stroke thrombolysis. J Clin Neurosci. 2009;16:501-504

270. De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, Parsons M, Butcher K, Barber PA, Donnan GA, Davis S. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2009;40:2872-2874

271. Donnan G, Davis S. Ethics and feasibility of placebo-controlled interventional acute stroke trials (response). Stroke. 2009;40:E538

272. Donnan GA, Baron JC, Ma H, Davis S. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8:261-269

273. Donnan GA, Davis S. Angiotensin receptor blockers and stroke therapy: It is all about the blood pressure. Stroke. 2009;40:3163

274. Donnan GA, Davis S. IV and IA thrombolytic stroke strategies are complementary. Stroke. 2009;40:2615

275. Donnan GA, Davis S. Combined aspirin plus warfarin: Recent evidence and residual questions. Stroke. 2009;40:1946

276. Donnan GA, Davis S. The ethics of thrombolytic trials beyond 3 (or 4.5) hours: Randomized controlled trials are required to change clinical practice. Stroke. 2009;40:1545

277. Ebinger M, Christensen S, De Silva DA, Parsons MW, Levi CR, Butcher KS, Bladin CF, Barber PA, Donnan GA, Davis S. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke. 2009;40:1353-1358

278. Ebinger M, De Silva DA, Christensen S, Parsons MW, Markus R, Donnan GA, Davis S. Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci. 2009;16:178-187

279. Ebinger M, Iwanaga T, Prosser JF, De Silva DA, Christensen S, Collins M, Parsons MW, Levi CR, Bladin CF, Barber PA, Donnan GA, Davis S. Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke. Stroke. 2009;40:2572-2574

280. Joubert J, Reid C, Barton D, Cumming T, McLean A, Joubert L, Barlow J, Ames D, Davis S. Integrated care improves risk-factor modification after stroke: Initial results of the integrated care for the reduction of secondary stroke model. J Neurol Neurosurg Psychiatry. 2009;80:279-284

281. Kidwell CS, Lees KR, Muir KW, Chen C, Davis S, De Silva DA, Weir CJ, Starkman S, Alger JR, Saver JL. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke. 2009;40:1704-1709

282. Levi C, Lindley RI, Smith B, Bladin C, Parsons M, Read S, Cadilhac D, Donnan G, Davis S, al. E. The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the national stroke foundation and the stroke society of Australasia. Internal Medicine Journal. 2009;39:317-324

283. Ma H, Zavala JA, Teoh H, Churilov L, Gunawan M, Ly J, Wright P, Phan T, Arakawa S, Davis S, Donnan GA. Fragmentation of the classical magnetic resonance mismatch "Penumbral" Pattern with time. Stroke. 2009;40:3752-3757

284. Ma H, Zavala JA, Teoh H, Churilov L, Gunawan M, Ly J, Wright P, Phan T, Arakawa S, Davis S, Donnan GA. Penumbral mismatch is underestimated using standard volumetric methods and this is exacerbated with time. J Neurol Neurosurg Psychiatry. 2009;80:991-996

285. Mayer SA, Davis S, Skolnick BE, Brun NC, Begtrup K, Broderick JP, Diringer MN, Steiner T. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated Factor VII? Stroke. 2009;40:833-840

286. Teal P, Davis S, Hacke W, Kaste M, Lyden PD, Fierus M. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: Modified randomized exposure controlled trial (MRECT). Stroke. 2009;40:3518-3525

287. Ali M, Sacco RL, Lees KR, VISTA investigators. Primary end-point times, functional outcome and adverse event profile after acute ischaemic stroke. Int J Stroke 2009;4:432-442.

288. Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, Jeerakathil T, Campbell BC, Barber PA, Bladin C, Fink J, Tress B, Donnan GA, Davis S. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010;41:72-77

289. Campbell BC, Christensen S, Butcher KS, Gordon I, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, De Silva DA, Donnan GA, Davis S. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke. 2010;41:82-88

290. Davis S, Donnan GA. Clot retrieval for stroke: 'yes we can,' but priority for trials and registries. Stroke. 2010;41:196

291. De Silva DA, Brekenfeld C, Ebinger M, Christensen S, Barber PA, Butcher KS, Levi CR, Parsons MW, Bladin CF, Donnan GA, Davis S. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2010;41:295-299

292. De Silva DA, Ebinger M, Christensen S, Parsons MW, Levi C, Butcher K, Barber PA, Bladin C, Donnan GA, Davis S. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis. 2010;29:14-21

293. Dewey HM, Churilov L, Blacker D, Bladin C, Davis S, Donnan GA, Gates P, Gerraty RP, Hand P, Levi C, Lindley RI, Markus R, Read S. Response to "A graphic reanalysis of the NINDS trial". Ann Emerg Med. 2010;55:227-229; author reply 229

294. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis S, Brun NC, Broderick JP. Thromboembolic events with recombinant activated Factor VII in spontaneous intracerebral hemorrhage: Results from the factor seven for acute hemorrhagic stroke (FAST) trial. Stroke. 2010;41:48-53

295. Donnan GA, Hankey GJ, Davis S. Intracerebral haemorrhage: A need for more data and new research directions. Lancet Neurol. 2010;9:133-134

296. Mishra NK, Albers GW, Davis S, Donnan GA, Furlan AJ, Hacke W, Lees KR. Mismatch-based delayed thrombolysis: A meta-analysis. Stroke. 2010;41:e25-33

297. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, Ebinger M, Barber PA, Bladin C, Donnan GA, Davis S. Pretreatment diffusion- and perfusion-mr lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010

298. Campbell BC, Christensen S, Foster S, Desmond P, Parsons M, Butcher K, Barber PA, Levi C, Bladin C, Donnan G, Davis S. Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis. Cerebrovasc Dis. 2010 29:592-596

299. Lees KR, Bluhmki E, Von Kummer R, Brott TG, Toni D, Grotta J, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC,
1   ...   7   8   9   10   11   12   13   14   15

Похожие:

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum Vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Curriculum vitae iconCurriculum vitae

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница